Strategies helps businesses and individuals solve the complexities of dealing with the government at every level. Our team of specialists concentrate exclusively on government affairs, representing clients nationwide who need assistance with public policy, advocacy, and government relations strategies.
This unique program provides innovative and affordable opportunities to startups and early-stage emerging companies with a solid technology or scientific foundation. We help companies that have a quality management team in place and do not have other significant legal representation.
eMerge’s lawyers and technologists work together to deliver strategic end-to-end eDiscovery and data management solutions for litigation, investigations, due diligence, and compliance matters. We help clients discover the information necessary to resolve disputes, respond to investigations, conduct due diligence, and comply with legal requirements.
Partner
More ways to contact Julie-Anne M. Lutfi
Additional Languages: French, Spanish, Arabic
Julie-Anne advises institutional investors and companies on M&A, SPACs, venture financings, and cross-border deals, with a focus on biotechnology, pharmaceuticals, digital health, and the broader health care and life sciences sector.
Julie-Anne counsels institutional investors and organizations in health care and other industries, with a particular focus on transactions involving biotechnology, pharmaceuticals, medtech, and digital health. Named “One to Watch” in corporate law by Best Lawyers, Julie-Anne handles mergers and acquisitions, SPAC transactions, venture financings, divestitures, joint ventures, restructurings, and other domestic and cross-border deals — including platform acquisitions, add-ons, and exits for private equity sponsors and venture investors.
Alongside transactional work, she also advises social enterprise firms, impact investors, and nonprofits on corporate governance, sustainability, and impact measurement.
Julie-Anne has helped a range of clients — from leading health systems to manufacturers, large tech companies, and AI-powered SaaS platforms — close their most important deals. In the health care and life sciences space, she has handled deals spanning clinical trials, wound care, women’s health, urgent care, ophthalmology, and medical devices.
Before focusing on corporate transactions, Julie-Anne was tax and corporate counsel at Credit Suisse AG, where she advised high-net-worth and ultra-high-net-worth individuals on international tax matters and estate planning using trusts, foundations, and other wealth structuring vehicles — experience that shapes how she thinks about the tax dimensions of complex, multijurisdictional deals.
Education
Bar Admissions
Languages
